Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Bullboard Posts
Comment by juniper88on Dec 03, 2018 11:36am
81 Views
Post# 29054319

RE:RE:RE:New CCO

RE:RE:RE:New CCO
His full resume is available on Linkedin.
Left Bmy in Oct after only 2 years
Previously at Abbvie for only 1 year and 9 mos
Previously at Abbot for 8 yrs and 2 mos 
Previously Axcan just over 3 year

Has vast experience geographically and with many profucts
Maybe not a super star but he probably has the right tools for TH 

Maybe Spceo could find out why he left BMY —- it appears that he was let go but the PR does not provide more details


I can't say I am particularly impressed by his resume, I was hoping for someone better.  I don't see anything about HIV on his resume.  Also, how did he get to be out of a job since October?  That is all Thera could come up with, someone who is unemployed.  I am not saying an unemployed person cannot be good, but I guess I was hope for someone better.   

Palinc, I am reasonable sure this was not the catalyst you were looking for...
Bullboard Posts